Skip to content
Clinical Trials – home

PARACETAMOL DC: A Comprehensive Overview for Patients

0 / 5
trials open to patients / all trials
9+
Countries

In short

This article summarizes several clinical trials investigating the use of Paracetamol DC, a common pain reliever and fever reducer, in various medical conditions. The trials explore its potential benefits and safety profile when used alone or in combination with other treatments for conditions ranging from multiple myeloma to lymphoma. While Paracetamol DC is not the primary focus of most trials, it is included as a supportive medication in some study protocols.

Introduction

PARACETAMOL DC is a widely used medication that plays a crucial role in managing pain and fever. This article aims to provide patients with a comprehensive understanding of PARACETAMOL DC, its uses, benefits, and potential risks.

What is PARACETAMOL DC?

PARACETAMOL DC is a pharmaceutical formulation containing paracetamol, also known as acetaminophen. The "DC" in the name likely stands for "Direct Compression," which refers to a specific manufacturing process used to produce the medication. PARACETAMOL DC is part of a group of medications called analgesics (pain relievers) and antipyretics (fever reducers).

Medical Uses

PARACETAMOL DC is used to treat a variety of conditions, including:

  • Pain relief: It can help alleviate mild to moderate pain associated with headaches, toothaches, menstrual cramps, arthritis, backaches, and other types of pain.
  • Fever reduction: It is effective in reducing fever associated with various illnesses.
  • Auxiliary treatment in various medical conditions: PARACETAMOL DC is often used as a supportive treatment in conjunction with other medications for conditions such as:
    • Multiple myeloma
    • Acute myocardial infarction (heart attack)
    • Various types of cancer, including urothelial, cervical, ovarian, and prostate cancer
    • Hodgkin and non-Hodgkin lymphoma

Dosage and Administration

The dosage of PARACETAMOL DC can vary depending on the specific condition being treated and the patient's individual needs. However, based on the available information from clinical trials, some general guidelines can be provided:

  • Typical daily dosage: The maximum daily dose generally ranges from 650 mg to 4000 mg.
  • Administration route: PARACETAMOL DC is usually taken orally, but in some cases, it may be administered intravenously.
  • Frequency: The medication can be taken as needed or on a regular schedule, depending on the doctor's instructions.

It's crucial to follow your healthcare provider's instructions and never exceed the recommended dose, as overdosing on paracetamol can lead to severe liver damage.

Side Effects and Safety

While PARACETAMOL DC is generally considered safe when used as directed, it can cause side effects in some people. Common side effects may include:

  • Nausea
  • Stomach pain
  • Loss of appetite
  • Headache
  • Skin rash or itching

In rare cases, more serious side effects can occur. Seek immediate medical attention if you experience:

  • Signs of an allergic reaction (rash, itching, swelling, severe dizziness, difficulty breathing)
  • Signs of liver problems (persistent nausea/vomiting, loss of appetite, stomach/abdominal pain, yellowing eyes/skin, dark urine)

Precautions and Contraindications

Before taking PARACETAMOL DC, inform your doctor if you have:

  • Liver disease or a history of alcohol abuse
  • Kidney disease
  • Any allergies to medications

Pregnant and breastfeeding women should consult their healthcare provider before using PARACETAMOL DC.

Drug Interactions

PARACETAMOL DC may interact with other medications. It's important to inform your healthcare provider about all the medications you're taking, including prescription drugs, over-the-counter medicines, and herbal supplements. Some potential interactions include:

  • Warfarin (blood thinner)
  • Certain anti-epileptic medications
  • Medications that affect liver function

Ongoing Research

PARACETAMOL DC is being studied as an auxiliary treatment in various clinical trials, including:

  • A study on its use in combination with other medications for multiple myeloma
  • Research on its role in managing pain and fever in patients with acute myocardial infarction
  • Investigations into its supportive role in cancer treatments
  • Studies on its use in lymphoma treatments

These ongoing studies aim to further understand the potential benefits and optimal use of PARACETAMOL DC in various medical conditions.

Conclusion

PARACETAMOL DC is a versatile and widely used medication for pain relief and fever reduction. While it is generally safe when used as directed, it's important to follow dosage instructions carefully and be aware of potential side effects and interactions. Always consult with your healthcare provider for personalized advice on using PARACETAMOL DC, especially if you have any underlying health conditions or are taking other medications.

Questions people often ask

Conditions where Paracetamol Dc is being studied

Each condition opens its own overview and trial list

Trials with Paracetamol Dc

Recruiting trials first

See all 5 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).